ArticleCureus2025
Orbital Rhabdomyosarcoma With Bone Marrow Involvement: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhabdomyosarcoma (RMS) is the most common primary malignant orbital tumor in children and is very rare in adults. Bone marrow (BM) infiltration is an unusual site of metastasis and is associated with a poor prognosis; therefore, management must be initiated as promptly as possible. We report the case of a 32-year-old adult with no significant medical history, presenting with embryonal orbital RMS accompanied by BM infiltration. Clinical examination revealed decreased visual acuity with ptosis, palpebral edema, and exophthalmos, all evolving in the context of general health deterioration. Treatment consisted of chemotherapy; however, the outcome after the first cycle was unexpected. This case highlights the aggressiveness of embryonal RMS (ERMS) in adults and underscores the importance of rapid and appropriate management through a multimodal therapeutic approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.